LL-37 Inhibits EV71 Infection by Upregulating STAC via the EGFR-ERK Signaling Pathway
Viruses · 07.04.2026 · 18 (4) · 442
DOI: 10.3390/v18040442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 07.04.2026. Verfasst von Jiaqi Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Chinese People's Liberation Army, Beijing 100853, China. Hauptthemen laut MEDLINE: Enterovirus A, Human, Antimicrobial Cationic Peptides, Enterovirus Infections, MAP Kinase Signaling System. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
LL-37, a 37-amino acid human-derived antimicrobial peptide, was shown in our earlier clinical study to shorten the negative conversion time of the Omicron BA.5.1.3 variant of SARS-CoV-2. In this work, we investigated the broad mechanism of LL-37 by examining its inhibitory effect on non-enveloped virus Enterovirus 71 (EV71). LL-37 treatment dose-dependently reduced EV71 viral RNA abundance, suppressed virus-encoded protein expression, and decreased infectious titers, acting predominantly at a post-entry stage of the viral life cycle. Transcriptomic analysis revealed that the SH3 and cysteine-rich domain protein (Stac) was uniquely upregulated by LL-37 irrespective of EV71 infection. Short hairpin RNA (shRNA)-mediated Stac silencing significantly enhanced EV71 infection, while Stac overexpression markedly reduced it. Furthermore, we found that LL-37 activates the EGFR–ERK signaling pathway, leading to time-dependent upregulation of Stac expression. These findings uncover a novel host-directed mechanism by which LL-37 combats EV71 infection and suggests a potential therapeutic use of LL-37 against non-enveloped viral disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical School of Chinese People's Liberation Army, Beijing 100853, China.
- Department of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing 100853, China.
- State Key Laboratory of Animal Biodiversity Conservation and Integrated Pest Management, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing 101408, China.
ORCID-Profile: Yi Chen, Zhe Luan, Yujian Zhang, Meng Dong
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- China Postdoctoral Science Foundation
- Research on Health Beneficial Bacteria and Metabolites to Enhance Military Operational Capability
- Hospital’s “3 + 1” Innovative Talent Program
Zitieren
APA
Zhang, J., Zhang, H., Chen, Y., Liu, H., Peng, S., Zhao, J., Luan, Z., Zhang, Y., Dong, M., Jin, W., & Sun, G. (2026). LL-37 Inhibits EV71 Infection by Upregulating STAC via the EGFR-ERK Signaling Pathway. Viruses, 18(4), 442. https://doi.org/10.3390/v18040442
Vancouver
Zhang J, Zhang H, Chen Y, Liu H, Peng S, Zhao J, et al. LL-37 Inhibits EV71 Infection by Upregulating STAC via the EGFR-ERK Signaling Pathway. Viruses. 2026;18(4):442. doi:10.3390/v18040442
BibTeX
@article{Zhang2026,
author = {Zhang, Jiaqi and Zhang, Hanlin and Chen, Yi and Liu, Hanfei and Peng, Shuhuang and Zhao, Jiwei and Luan, Zhe and Zhang, Yujian and Dong, Meng and Jin, Wanzhu and Sun, Gang},
title = {LL-37 Inhibits EV71 Infection by Upregulating STAC via the EGFR-ERK Signaling Pathway},
journal = {Viruses},
year = {2026},
volume = {18},
number = {4},
pages = {442},
doi = {10.3390/v18040442}
}
EUVIMED